HEADER LIGASE 23-OCT-02 1N2O TITLE CRYSTAL STRUCTURE OF PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS, LOW TITLE 2 OCCUPANCY OF BETA-ALANINE AT THE PANTOATE BINDING SITES COMPND MOL_ID: 1; COMPND 2 MOLECULE: PANTOTHENATE SYNTHETASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PANTOATE--BETA-ALANINE LIGASE, PANTOATE ACTIVATING ENZYME; COMPND 5 EC: 6.3.2.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: PANC; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET30A KEYWDS STRUCTURAL GENOMICS, ROSSMANN FOLD, DIMER, INTERSUBUNIT BETA SHEET, KEYWDS 2 PSI, PROTEIN STRUCTURE INITIATIVE, TB STRUCTURAL GENOMICS KEYWDS 3 CONSORTIUM, TBSGC, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR S.WANG,D.EISENBERG,TB STRUCTURAL GENOMICS CONSORTIUM (TBSGC) REVDAT 6 27-OCT-21 1N2O 1 REMARK SEQADV REVDAT 5 13-JUL-11 1N2O 1 VERSN REVDAT 4 24-FEB-09 1N2O 1 VERSN REVDAT 3 01-FEB-05 1N2O 1 AUTHOR KEYWDS REMARK REVDAT 2 20-MAY-03 1N2O 1 JRNL REVDAT 1 23-APR-03 1N2O 0 JRNL AUTH S.WANG,D.EISENBERG JRNL TITL CRYSTAL STRUCTURES OF A PANTOTHENATE SYNTHETASE FROM M. JRNL TITL 2 TUBERCULOSIS AND ITS COMPLEXES WITH SUBSTRATES AND A JRNL TITL 3 REACTION INTERMEDIATE JRNL REF PROTEIN SCI. V. 12 1097 2003 JRNL REFN ISSN 0961-8368 JRNL PMID 12717031 JRNL DOI 10.1110/PS.0241803 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 33694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2710 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5066 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE : 0.2950 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 449 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4119 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 192 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.25000 REMARK 3 B22 (A**2) : 8.18000 REMARK 3 B33 (A**2) : -10.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.24 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.080 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.960 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.800 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.130 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.240 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 52.39 REMARK 3 REMARK 3 NCS MODEL : RESTRAIN REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : LIGANDS_1.PAR REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : LIGANDS.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: LOW OCCUPANCY OF BETA-ALANINE, BUT AT REMARK 3 THE PANTOATE BINDING SITES INSTEAD. REMARK 4 REMARK 4 1N2O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-NOV-02. REMARK 100 THE DEPOSITION ID IS D_1000017442. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-D REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33810 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : 0.08100 REMARK 200 FOR THE DATA SET : 25.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.60 REMARK 200 R MERGE FOR SHELL (I) : 0.59700 REMARK 200 R SYM FOR SHELL (I) : 0.59700 REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1MOP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3000, MAGNESIUM CHLORIDE, REMARK 280 IMIDAZOLE, ETHANOL, BETA-ALANINE, PH 8.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.87350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.05100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.32400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.05100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.87350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.32400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A DIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ILE A 3 REMARK 465 GLY A 76 REMARK 465 GLY A 77 REMARK 465 ASP A 78 REMARK 465 LEU A 79 REMARK 465 ASP A 80 REMARK 465 ALA A 81 REMARK 465 TYR A 82 REMARK 465 PHE A 290 REMARK 465 ALA A 291 REMARK 465 GLY A 292 REMARK 465 THR A 293 REMARK 465 ASP A 294 REMARK 465 ARG A 295 REMARK 465 PRO A 296 REMARK 465 ASP A 297 REMARK 465 GLY A 298 REMARK 465 TYR A 299 REMARK 465 ARG A 300 REMARK 465 GLY B 74 REMARK 465 ALA B 75 REMARK 465 GLY B 76 REMARK 465 GLY B 77 REMARK 465 ASP B 78 REMARK 465 LEU B 79 REMARK 465 ASP B 80 REMARK 465 ALA B 81 REMARK 465 TYR B 82 REMARK 465 THR B 289 REMARK 465 PHE B 290 REMARK 465 ALA B 291 REMARK 465 GLY B 292 REMARK 465 THR B 293 REMARK 465 ASP B 294 REMARK 465 ARG B 295 REMARK 465 PRO B 296 REMARK 465 ASP B 297 REMARK 465 GLY B 298 REMARK 465 TYR B 299 REMARK 465 ARG B 300 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 133 C - N - CA ANGL. DEV. = 10.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 58 -87.98 -16.37 REMARK 500 ARG A 115 -82.40 -109.18 REMARK 500 LEU A 127 -109.70 47.21 REMARK 500 ARG B 115 -98.51 -95.78 REMARK 500 LEU B 127 -110.16 44.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BAL B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BAL A 802 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MOP RELATED DB: PDB REMARK 900 APO ENZYME STRUCTURE OF M. TUBERCULOSIS PANTOTHENATE SYNTHETASE REMARK 900 RELATED ID: 1N2B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS REMARK 900 IN COMPLEX WITH AMPCPP AND PANTOATE (BETTER OCCUPANCY OF PANTOATE REMARK 900 MOLECULE THAN 1N2E) REMARK 900 RELATED ID: 1N2E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS REMARK 900 IN COMPLEX WITH AMPCPP AND PANTOATE REMARK 900 RELATED ID: 1N2G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE IN COMPLEX WITH REMARK 900 AMPCPP REMARK 900 RELATED ID: 1N2H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS REMARK 900 IN COMPLEX WITH A REACTION INTERMEDIATE, PANTOYL ADENYLATE REMARK 900 RELATED ID: 1N2I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS REMARK 900 IN COMPLEX WITH A REACTION INTERMEDIATE, PANTOYL ADENYLATE, REMARK 900 DIFFERENT OCCUPANCIES OF PANTOYL ADENYLATE. REMARK 900 RELATED ID: 1N2J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS REMARK 900 IN COMPLEX WITH PANTOATE REMARK 900 RELATED ID: RV3602C RELATED DB: TARGETDB DBREF 1N2O A 1 300 UNP P0A5R0 PANC_MYCTU 1 300 DBREF 1N2O B 1 300 UNP P0A5R0 PANC_MYCTU 1 300 SEQADV 1N2O ALA A 2 UNP P0A5R0 THR 2 ENGINEERED MUTATION SEQADV 1N2O GLY A 77 UNP P0A5R0 GLU 77 ENGINEERED MUTATION SEQADV 1N2O ALA B 2 UNP P0A5R0 THR 2 ENGINEERED MUTATION SEQADV 1N2O GLY B 77 UNP P0A5R0 GLU 77 ENGINEERED MUTATION SEQRES 1 A 300 MET ALA ILE PRO ALA PHE HIS PRO GLY GLU LEU ASN VAL SEQRES 2 A 300 TYR SER ALA PRO GLY ASP VAL ALA ASP VAL SER ARG ALA SEQRES 3 A 300 LEU ARG LEU THR GLY ARG ARG VAL MET LEU VAL PRO THR SEQRES 4 A 300 MET GLY ALA LEU HIS GLU GLY HIS LEU ALA LEU VAL ARG SEQRES 5 A 300 ALA ALA LYS ARG VAL PRO GLY SER VAL VAL VAL VAL SER SEQRES 6 A 300 ILE PHE VAL ASN PRO MET GLN PHE GLY ALA GLY GLY ASP SEQRES 7 A 300 LEU ASP ALA TYR PRO ARG THR PRO ASP ASP ASP LEU ALA SEQRES 8 A 300 GLN LEU ARG ALA GLU GLY VAL GLU ILE ALA PHE THR PRO SEQRES 9 A 300 THR THR ALA ALA MET TYR PRO ASP GLY LEU ARG THR THR SEQRES 10 A 300 VAL GLN PRO GLY PRO LEU ALA ALA GLU LEU GLU GLY GLY SEQRES 11 A 300 PRO ARG PRO THR HIS PHE ALA GLY VAL LEU THR VAL VAL SEQRES 12 A 300 LEU LYS LEU LEU GLN ILE VAL ARG PRO ASP ARG VAL PHE SEQRES 13 A 300 PHE GLY GLU LYS ASP TYR GLN GLN LEU VAL LEU ILE ARG SEQRES 14 A 300 GLN LEU VAL ALA ASP PHE ASN LEU ASP VAL ALA VAL VAL SEQRES 15 A 300 GLY VAL PRO THR VAL ARG GLU ALA ASP GLY LEU ALA MET SEQRES 16 A 300 SER SER ARG ASN ARG TYR LEU ASP PRO ALA GLN ARG ALA SEQRES 17 A 300 ALA ALA VAL ALA LEU SER ALA ALA LEU THR ALA ALA ALA SEQRES 18 A 300 HIS ALA ALA THR ALA GLY ALA GLN ALA ALA LEU ASP ALA SEQRES 19 A 300 ALA ARG ALA VAL LEU ASP ALA ALA PRO GLY VAL ALA VAL SEQRES 20 A 300 ASP TYR LEU GLU LEU ARG ASP ILE GLY LEU GLY PRO MET SEQRES 21 A 300 PRO LEU ASN GLY SER GLY ARG LEU LEU VAL ALA ALA ARG SEQRES 22 A 300 LEU GLY THR THR ARG LEU LEU ASP ASN ILE ALA ILE GLU SEQRES 23 A 300 ILE GLY THR PHE ALA GLY THR ASP ARG PRO ASP GLY TYR SEQRES 24 A 300 ARG SEQRES 1 B 300 MET ALA ILE PRO ALA PHE HIS PRO GLY GLU LEU ASN VAL SEQRES 2 B 300 TYR SER ALA PRO GLY ASP VAL ALA ASP VAL SER ARG ALA SEQRES 3 B 300 LEU ARG LEU THR GLY ARG ARG VAL MET LEU VAL PRO THR SEQRES 4 B 300 MET GLY ALA LEU HIS GLU GLY HIS LEU ALA LEU VAL ARG SEQRES 5 B 300 ALA ALA LYS ARG VAL PRO GLY SER VAL VAL VAL VAL SER SEQRES 6 B 300 ILE PHE VAL ASN PRO MET GLN PHE GLY ALA GLY GLY ASP SEQRES 7 B 300 LEU ASP ALA TYR PRO ARG THR PRO ASP ASP ASP LEU ALA SEQRES 8 B 300 GLN LEU ARG ALA GLU GLY VAL GLU ILE ALA PHE THR PRO SEQRES 9 B 300 THR THR ALA ALA MET TYR PRO ASP GLY LEU ARG THR THR SEQRES 10 B 300 VAL GLN PRO GLY PRO LEU ALA ALA GLU LEU GLU GLY GLY SEQRES 11 B 300 PRO ARG PRO THR HIS PHE ALA GLY VAL LEU THR VAL VAL SEQRES 12 B 300 LEU LYS LEU LEU GLN ILE VAL ARG PRO ASP ARG VAL PHE SEQRES 13 B 300 PHE GLY GLU LYS ASP TYR GLN GLN LEU VAL LEU ILE ARG SEQRES 14 B 300 GLN LEU VAL ALA ASP PHE ASN LEU ASP VAL ALA VAL VAL SEQRES 15 B 300 GLY VAL PRO THR VAL ARG GLU ALA ASP GLY LEU ALA MET SEQRES 16 B 300 SER SER ARG ASN ARG TYR LEU ASP PRO ALA GLN ARG ALA SEQRES 17 B 300 ALA ALA VAL ALA LEU SER ALA ALA LEU THR ALA ALA ALA SEQRES 18 B 300 HIS ALA ALA THR ALA GLY ALA GLN ALA ALA LEU ASP ALA SEQRES 19 B 300 ALA ARG ALA VAL LEU ASP ALA ALA PRO GLY VAL ALA VAL SEQRES 20 B 300 ASP TYR LEU GLU LEU ARG ASP ILE GLY LEU GLY PRO MET SEQRES 21 B 300 PRO LEU ASN GLY SER GLY ARG LEU LEU VAL ALA ALA ARG SEQRES 22 B 300 LEU GLY THR THR ARG LEU LEU ASP ASN ILE ALA ILE GLU SEQRES 23 B 300 ILE GLY THR PHE ALA GLY THR ASP ARG PRO ASP GLY TYR SEQRES 24 B 300 ARG HET SO4 A 601 5 HET BAL A 802 6 HET SO4 B 602 5 HET BAL B 801 6 HETNAM SO4 SULFATE ION HETNAM BAL BETA-ALANINE FORMUL 3 SO4 2(O4 S 2-) FORMUL 4 BAL 2(C3 H7 N O2) FORMUL 7 HOH *192(H2 O) HELIX 1 1 ALA A 16 THR A 30 1 15 HELIX 2 2 HIS A 44 ARG A 56 1 13 HELIX 3 3 PRO A 70 GLY A 74 5 5 HELIX 4 4 PRO A 86 GLU A 96 1 11 HELIX 5 5 THR A 105 TYR A 110 1 6 HELIX 6 6 GLY A 121 GLY A 130 5 10 HELIX 7 7 THR A 134 ARG A 151 1 18 HELIX 8 8 ASP A 161 PHE A 175 1 15 HELIX 9 9 SER A 196 LEU A 202 5 7 HELIX 10 10 ASP A 203 ALA A 210 1 8 HELIX 11 11 VAL A 211 ALA A 224 1 14 HELIX 12 12 GLY A 227 ALA A 241 1 15 HELIX 13 13 ALA B 16 THR B 30 1 15 HELIX 14 14 HIS B 44 ARG B 56 1 13 HELIX 15 15 ASN B 69 PHE B 73 5 5 HELIX 16 16 THR B 85 GLY B 97 1 13 HELIX 17 17 THR B 105 TYR B 110 1 6 HELIX 18 18 GLY B 121 GLY B 130 5 10 HELIX 19 19 THR B 134 ARG B 151 1 18 HELIX 20 20 ASP B 161 PHE B 175 1 15 HELIX 21 21 SER B 196 LEU B 202 5 7 HELIX 22 22 ASP B 203 ALA B 210 1 8 HELIX 23 23 VAL B 211 ALA B 224 1 14 HELIX 24 24 GLY B 227 ALA B 241 1 15 SHEET 1 A 6 ASN A 12 TYR A 14 0 SHEET 2 A 6 ILE A 100 PHE A 102 1 O ALA A 101 N TYR A 14 SHEET 3 A 6 SER A 60 ILE A 66 1 N VAL A 64 O ILE A 100 SHEET 4 A 6 ARG A 33 THR A 39 1 N MET A 35 O VAL A 63 SHEET 5 A 6 ARG A 154 GLY A 158 1 O ARG A 154 N LEU A 36 SHEET 6 A 6 ALA A 180 VAL A 184 1 O VAL A 182 N VAL A 155 SHEET 1 B 2 THR A 117 GLN A 119 0 SHEET 2 B 2 THR B 117 GLN B 119 -1 O THR B 117 N GLN A 119 SHEET 1 C 3 ALA A 246 ASP A 254 0 SHEET 2 C 3 GLY A 264 LEU A 274 -1 O LEU A 269 N GLU A 251 SHEET 3 C 3 THR A 277 ILE A 287 -1 O LEU A 279 N ALA A 272 SHEET 1 D 6 ASN B 12 TYR B 14 0 SHEET 2 D 6 ILE B 100 PHE B 102 1 O ALA B 101 N TYR B 14 SHEET 3 D 6 SER B 60 ILE B 66 1 N VAL B 64 O ILE B 100 SHEET 4 D 6 ARG B 33 THR B 39 1 N MET B 35 O VAL B 63 SHEET 5 D 6 ARG B 154 GLY B 158 1 O PHE B 156 N LEU B 36 SHEET 6 D 6 ALA B 180 VAL B 184 1 O VAL B 182 N VAL B 155 SHEET 1 E 3 ALA B 246 ARG B 253 0 SHEET 2 E 3 GLY B 264 LEU B 274 -1 O ARG B 267 N ARG B 253 SHEET 3 E 3 THR B 277 ILE B 287 -1 O THR B 277 N LEU B 274 SITE 1 AC1 4 HIS A 44 SER A 196 SER A 197 ARG A 198 SITE 1 AC2 4 HIS B 44 HIS B 47 SER B 196 SER B 197 SITE 1 AC3 4 GLN B 72 VAL B 142 GLN B 164 HOH B 843 SITE 1 AC4 4 PHE A 67 VAL A 142 LEU A 146 HOH A 803 CRYST1 69.747 98.648 82.102 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014338 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010137 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012180 0.00000 MASTER 351 0 4 24 20 0 4 6 0 0 0 48 END